Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Basilar artery thrombosis.
Richardson PG. Richardson PG. Emerg Med (Fremantle). 2001 Sep;13(3):367-72. doi: 10.1046/j.1035-6851.2001.00242.x. Emerg Med (Fremantle). 2001. PMID: 11554871
Snakebite in herpetologists.
Pearn JH, Covacevich J, Charles N, Richardson P. Pearn JH, et al. Among authors: richardson p. Med J Aust. 1994 Dec 5-19;161(11-12):706-8. Med J Aust. 1994. PMID: 7830644
Use of defibrotide in COVID-19 pneumonia: comparison of a phase II study and a matched real-world cohort control.
Ruggeri A, Corrado F, Voza A, Wei LJ, Catalano G, Liberatore C, Nitti R, Fedeli C, Bruno A, Calabretta E, Giglio F, Sciutti F, Lunghi F, Landoni G, Aghemo A, Iacobelli M, Querini PR, Richardson PG, Assanelli A, Peccatori J, Ciceri F, Carlo-Stella C. Ruggeri A, et al. Among authors: richardson pg. Haematologica. 2024 May 23. doi: 10.3324/haematol.2024.285345. Online ahead of print. Haematologica. 2024. PMID: 38779740 Free article.
Discovery of N-X anomeric amides as electrophilic halogenation reagents.
Wang Y, Bi C, Kawamata Y, Grant LN, Samp L, Richardson PF, Zhang S, Harper KC, Palkowitz MD, Vasilopoulos A, Collins MR, Oderinde MS, Tyrol CC, Chen D, LaChapelle EA, Bailey JB, Qiao JX, Baran PS. Wang Y, et al. Among authors: richardson pf. Nat Chem. 2024 May 20. doi: 10.1038/s41557-024-01539-4. Online ahead of print. Nat Chem. 2024. PMID: 38769366
Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone.
Nadeem O, Aranha MP, Redd R, Timonian M, Magidson S, Lightbody ED, Alberge JB, Bertamini L, Dutta AK, El-Khoury H, Bustoros M, Laubach JP, Bianchi G, O'Donnell E, Wu T, Tsuji J, Anderson K, Getz G, Trippa L, Richardson PG, Sklavenitis-Pistofidis R, Ghobrial IM. Nadeem O, et al. Among authors: richardson pg. medRxiv [Preprint]. 2024 Apr 19:2024.04.19.24306082. doi: 10.1101/2024.04.19.24306082. medRxiv. 2024. PMID: 38699307 Free PMC article. Preprint.
Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial.
Mateos MV, Engelhardt M, Leleu X, Mesa MG, Cavo M, Dimopoulos M, Bianco M, Merlo GM, Porte C, Richardson PG, Moreau P. Mateos MV, et al. Among authors: richardson pg. Eur J Haematol. 2024 May 1. doi: 10.1111/ejh.14223. Online ahead of print. Eur J Haematol. 2024. PMID: 38693052
2,364 results